
REMINDER: A doctor&rsquo,s prescription is required to purchase this product. To avoid delay in delivery or cancellation of your order ,(before the item is SHIPPED), please email a copy of your prescription (.jpeg or .pdf file format) to ,OnlinePharmacy@watsons.com.ph ,with your order number after Checkout. Our pharmacist will also get in touch with you to validate your prescription. Please be ready to show your original prescription upon claiming/delivery of your order.
,
,
,
Type 2 diabetes mellitus
[Pioglitazone (Actos) Tablets should be used only in patients who do not sufficiently respond to any of the following treatments and are suspected to be insulin resistant:
a. Dietary treatment and exercise therapy alone
b. Using sulfonylureas in addition to dietary treatment and/or exercise therapy
c. Using &alpha,-glucosidase inhibitors in addition to dietary treatment and/or exercise therapy
d. Using biguanides in addition to dietary treatment and/or exercise therapy
e. Using insulin preparation in addition to dietary treatment and/or exercise therapy
Place of Origin
Japan
Product Usage
DOSAGE AND ADMINISTRATION:
1. When Pioglitazone (Actos) is used in addition to dietary treatment and/or exercise therapy alone or in combination of dietary treatment and/or exercise therapy and sulfonylureas, α-glucosidase inhibitors or biguanides. Usually, for adults, 15–30mg of pioglitazone is orally administered once a day before or after breakfast. The dosage may be appropriately adjusted according to the patient’s sex, age and symptom within the upper limit of 45mg.
2. When Pioglitazone (Actos) is used in combination of dietary treatment and/or exercise therapy and insulin preparations. Usually, for adults, 15mg of pioglitazone is orally administered once a day before or after breakfast. The dosage may be appropriately adjusted according to the patient’s sex, age and symptom within the upper limit of 30mg.
Ingredients
Pioglitazone HCl
Warnings
CONTRAINDICATIONS:
[Pioglitazone (Actos) Tablets are contraindicated in the following patients].
(1) Patients with cardiac failure or a history of cardiac failure. [In animal studies
Width
1
Height
1
Depth
1